Open access
Open access
Powered by Google Translator Translator

All Posts

Chest CT in COVID-19: What the radiologist needs to know

28 Oct, 2020 | 08:59h | UTC

Chest CT in COVID-19: What the Radiologist Needs to Know – RadioGraphics

 

Meta-analysis: Most therapies for fibromyalgia are not supported by high-quality evidence

28 Oct, 2020 | 08:52h | UTC

Association of Therapies With Reduced Pain and Improved Quality of Life in Patients With Fibromyalgia: A Systematic Review and Meta-analysis – JAMA Internal Medicine (free for a limited period)

Commentary: Evidence Lacking for Most Fibromyalgia Treatments, Meta-Analysis Finds – NEJM Journal Watch

 

Observational Study: Ticagrelor, compared with clopidogrel, is not associated with better outcomes for patients with ACS treated with PCI

28 Oct, 2020 | 08:54h | UTC

Association of Ticagrelor vs Clopidogrel With Net Adverse Clinical Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention – JAMA (free for a limited period)

Editorial: Net Adverse Clinical Events With Antiplatelet Therapy in Acute Coronary Syndromes – JAMA (free for a limited period)

Author Interview: Ticagrelor or Clopidogrel for Antiplatelet Therapy After Percutaneous Intervention for Acute Coronary Syndrome? – JAMA

Commentary: Ticagrelor vs. Clopidogrel in Real-Life Patients with Acute Coronary Syndromes: Another View – NEJM Journal Watch

 

Commentary on Twitter

 

Systematic review: Antithrombotic drugs for people with antiphospholipid syndrome

28 Oct, 2020 | 08:50h | UTC

Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome – Cochrane Library

Summary: Anticoagulant drugs or antiplatelet drugs, or both, for reducing the risk of blood clots and stroke in people with antiphospholipid syndrome – Cochrane Library

 

Clinical review: New advances in the diagnosis and management of hepatocellular carcinoma

28 Oct, 2020 | 08:47h | UTC

New advances in the diagnosis and management of hepatocellular carcinoma – The BMJ (free for a limited period)

 

Commentary on Twitter

https://twitter.com/bmj_latest/status/1320817899599241216

 

[Abstract Only] Meta-analysis: Complication of vasopressor infusion through peripheral venous catheter

28 Oct, 2020 | 08:49h | UTC

Complication of vasopressor infusion through peripheral venous catheter: A systematic review and meta-analysis – The American Journal of Emergency Medicine (link to abstract – $ for full-text)

 

Commentary on Twitter

 

[Abstract Only] Study: Postpartum depression may persist three years after giving birth

28 Oct, 2020 | 08:46h | UTC

Postpartum depression may persist three years after giving birth – NIH News Releases

Original Study: Trajectories of Maternal Postpartum Depressive Symptoms – Pediatrics (link to abstract – $ for full-text)

 

Preventing the spread of SARS-CoV-2 with masks and other “low-tech” interventions

27 Oct, 2020 | 09:51h | UTC

Preventing the Spread of SARS-CoV-2 With Masks and Other “Low-tech” Interventions – JAMA

 

Commentary on Twitter

 

Radiation therapy for rectal cancer: Executive summary of an ASTRO clinical practice guideline

28 Oct, 2020 | 08:45h | UTC

Radiation Therapy for Rectal Cancer: Executive Summary of an ASTRO Clinical Practice Guideline – Practical Radiation Oncology

Commentaries: ASTRO issues clinical guideline on radiation therapy for rectal cancer AND ASTRO Issues Guideline on Radiation Therapy for Rectal Cancer – Physician’s Weekly

 

Commentary on Twitter

 

JACC Journal series gives in-depth look at COVID-19’s impact on the heart

27 Oct, 2020 | 09:49h | UTC

News release: Journal series gives in-depth look at COVID-19’s impact on the heart – American College of Cardiology

JACC Focus Seminar 1: Coronavirus and Cardiometabolic Syndrome

JACC Focus Seminar 2: Coronavirus Historical Perspective, Disease Mechanisms, and Clinical Outcomes

JACC Focus Seminar 3: Coronavirus and Cardiovascular Disease, Myocardial Injury, and Arrhythmia

 

SARS-CoV-2 antibodies detectable up to seven months post COVID-19 onset

27 Oct, 2020 | 09:44h | UTC

SARS-CoV-2 antibodies detectable up to seven months post COVID-19 onset – Instituto de Medicina Molecular

Original Study: Seroprevalence of anti‐SARS‐CoV‐2 antibodies in COVID‐19 patients and healthy volunteers up to six months post disease onset – European Journal of Immunology

 

Commentary on Twitter

 

COVID-19 – Lessons learned and questions remaining

27 Oct, 2020 | 09:46h | UTC

COVID-19 – Lessons Learned and Questions Remaining – Clinical Infectious Diseases

 

Commentary on Twitter

 

CDC Guideline – Wastewater Surveillance System: A new public health tool to understand COVID-19 spread in a community

27 Oct, 2020 | 09:47h | UTC

Introduction: National Wastewater Surveillance System – Centers for Disease Control and Prevention

 

Understanding protection from SARS-CoV-2 by studying reinfection

27 Oct, 2020 | 09:42h | UTC

Understanding protection from SARS-CoV-2 by studying reinfection – Nature Medicine

 

COVID-19 antibody responses are related to the severity of symptoms

27 Oct, 2020 | 09:43h | UTC

Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans – Nature Medicine

Commentaries: Studies show long-term COVID-19 immune response – CIDRAP AND COVID-19 immunity may be related to the severity of one’s symptoms, study finds – CTV News

 

Commentary on Twitter

 

Perspective: It’s time to talk about Covid-19 and surfaces again

27 Oct, 2020 | 09:39h | UTC

It’s Time to Talk About Covid-19 and Surfaces Again – Wired

 

Commentary on Twitter

 

Covid-19: Six feet is not enough and 15 minutes is too long

27 Oct, 2020 | 09:38h | UTC

Six Feet Is Not Enough and 15 Minutes Is Too Long – Medium

 

Review: Prospects for a safe COVID-19 vaccine

27 Oct, 2020 | 09:41h | UTC

Prospects for a safe COVID-19 vaccine – Science Translational Medicine

 

Observational study on the effectiveness of deep sedation for patients with intractable electrical storm refractory to antiarrhythmic drugs

27 Oct, 2020 | 09:34h | UTC

Effectiveness of Deep Sedation for Patients With Intractable Electrical Storm Refractory to Antiarrhythmic Drugs – Circulation

 

Commentary on Twitter

 

Randomized trial suggests rapid intermittent bolus of hypertonic saline is the best approach for the treatment of symptomatic hyponatremia

27 Oct, 2020 | 09:36h | UTC

Risk of Overcorrection in Rapid Intermittent Bolus vs Slow Continuous Infusion Therapies of Hypertonic Saline for Patients With Symptomatic Hyponatremia: The SALSA Randomized Clinical Trial – JAMA Internal Medicine

 

 

ASCO Guideline Update: Selection of optimal adjuvant chemotherapy and targeted therapy for early breast cancer

27 Oct, 2020 | 09:32h | UTC

Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Guideline Update – Journal of Clinical Oncology

 

FDA Safety Alert: Avoid use of NSAIDs in pregnancy at 20 weeks or later

27 Oct, 2020 | 09:33h | UTC

Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Drug Safety Communication – Avoid Use of NSAIDs in Pregnancy at 20 Weeks or Later – U.S. Food & Drug Administration

Commentary: FDA Expands Warning on Use of NSAIDs in Pregnancy – NEJM Journal Watch

 

Guideline: Airway management in adult trauma patients

27 Oct, 2020 | 09:30h | UTC

Western Trauma Association critical decisions in trauma: airway management in adult trauma patients – Trauma Surgery & Acute Care Open

 

Commentary on Twitter

 

Consensus statement: Recommendations for hemodynamic monitoring for critically ill children

27 Oct, 2020 | 09:31h | UTC

Recommendations for hemodynamic monitoring for critically ill children—expert consensus statement issued by the cardiovascular dynamics section of the European Society of Paediatric and Neonatal Intensive Care (ESPNIC) – Critical Care

 

Universal mask use could save 130,000 U.S. lives by the end of February, new study estimates

25 Oct, 2020 | 23:51h | UTC

Universal mask use could save 130,000 U.S. lives by the end of February, new study estimates – STAT

Original Study: Modeling COVID-19 scenarios for the United States – Nature Medicine

 

Commentary on Twitter

 

Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.